• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SALIX SOLESTA; GEL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SALIX SOLESTA; GEL Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problem Sepsis (2067)
Event Date 08/06/2014
Event Type  Injury  
Event Description
Pt admitted to hospital with sepsis within 24 hrs of solesta injection for fecal incontinence.Dose or amount: 1cc x 4 injections.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SOLESTA
Type of Device
GEL
Manufacturer (Section D)
SALIX
MDR Report Key4025109
MDR Text Key4845650
Report NumberMW5037807
Device Sequence Number1
Product Code LNM
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Physician
Type of Report Initial
Report Date 08/08/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received08/11/2014
Patient Sequence Number1
Treatment
LOPERAMIDE; FUROSEMIDE; VITRON-C; GLUCOSAMINE-CHONDROITIN; CARVEDILOL; METFORMIN; ZETIA; CRESTOR
Patient Outcome(s) Hospitalization;
Patient Age85 YR
Patient Weight81
-
-